C-
64/100
TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
TG Therapeutics Environment Employee Reviews
All
Positive
Constructive
What is most positive about the culture and environment at your company?
Nothing was positive. There was always gossip about other departments and there was always a lot of fake friendly interactions.
People are friendly and say "Hi" when they see you. Most everyone gets along
What needs to change to make the company culture better?
There shouldn’t be any nepotism
×